Several studies have proposed AFP as a marker that can be used to assess HCC responses to targeted chemotherapy because of its ability to discriminate patients with longer OS.22, 23, 24 Consequently, further studies should investigate the ability of combined radiological assessment plus AFP levels to predict OS. This evidence concerns the gene AFP and hepatocellular carcinoma.